Dr @ljlaffin presents the results of the #SPORT trial. Rosuva 5mg/d lowered LDL significantly more than 6 dietary supplements commonly used for cholesterol health. In fact no supplement lowered LDL-C more that placebo and garlic supplement actually raised LDL. #AHA22 @AHAScience ImageImageImageImage
Notably in this short term trial, no increase in musculoskeletal or neurological symptoms or worsening glycemia with rosuva 5. All participants with rosuva 5 had LDL lowering (coin toss for supplements), 50% had LDL>40% reduced with rosuva 5. #AHA22 ImageImageImageImage
77% of US adults take supplements and $50 billion is spent annually in US on supplements. But do they lower LDL? These supplements advertise that they help heart health but no better in lowering LDL than placebo not even red yeast rice. @ljlaffin #AHA22 @AHAScience ImageImageImageImage

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Erin D. Michos, M.D.

Erin D. Michos, M.D. Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ErinMichos

Jul 17, 2021
Now up, growing your program through modern media by @purviparwani. In current era, #SoMe is a powerful tool for growing your program. #SCCT2021 ImageImageImageImage
Strategies for growing your growing your advanced imaging program through modern media. Great talk by @purviparwani #SCCT2021 ImageImageImageImage
5 tips for growing #CardiacCT program @purviparwani #SCCT2021. Tip 1: Make imaging relevant to clinical problem. Tip 2: Imaging content on #SoMe. Tip 3: 80/20 rule of original content/promotion. Tip 4: 360 degree Marketing ImageImageImageImage
Read 4 tweets
Jul 17, 2021
#YesCCT : Clinical reporting & understanding finance by @docjuanb at #SCCT2021 . There are reimbursement challenges . #Cardiac CT is in the wrong Ambulatory Payment Classification (APC). Bill also must be supported by clinical symptom & diagnostic ICD10 codes. Not a “rule out”. ImageImageImageImage
Reimbursement tracks with the CPT used so use the right CPT code and make sure language in report supports that code. All CTA assumes 3D, thus need to mention 3D in report. Have your reporting align with @Heart_SCCT guidelines. @docjuanb at #SCCT2021 ImageImageImage
Unfortunately #cardiacCT often lumped into CT not cardiac. Hospitals should update cost charges to accurately reflect true cost of work, align w/ other cardiac testing. With costs underreported, CMS bases APC & reimbursement on these historically lower costs @docjuanb #SCCT2021 ImageImageImage
Read 4 tweets
Jul 17, 2021
Lessons learned in training your #yesCCT team by @appropriateuse #SCCT2021 : Step 1: Learn the current set-up. ImageImageImageImage
Lessons learned in training your #yesCCT team by @appropriateuse #SCCT2021 : Step 2: Expand the service. Step 3: Educating the team. ImageImageImageImage
Lessons learned in training your #yesCCT team by @appropriateuse #SCCT2021 : Step 4: Quality Assurance; Step 5: feedback; step 6: Management ImageImageImageImage
Read 4 tweets
Jul 16, 2021
Obstructive CAD is just one etiology of ischemia. If no obstructive disease, consider coronary microvascular dysfunction #CMD. So what is best imaging modality for CMD? @VTaqMD #SCCT2021 ImageImageImageImage
How to evaluate for #CMD? A multidimensional cardiac stress PET test can evaluation for perfusion, function, and coronary blood flow. @VTaqMD #SCCT2021 ImageImageImage
Distribution of risk by coronary flow reserve #CFR. Even in absence of inducible ischemia or obstructive lesions, impaired CFR is associated with increased CVD risk. When severely impaired, CFR more prognostically significant in women. @VTaqMD #SCCT2021 ImageImageImageImage
Read 6 tweets
Jul 16, 2021
Patients with #MINOCA were more likely to be women and have fewer traditional CV risk factors. Heterogenous pathophysiology – etiology is of great importance to guide treatment. Inge van den Hoogen #SCCT2021 ImageImageImageImage
#MINOCA diagnosis. Overt non-cardiac disorders need to be excluded. Also need to rule out missed obstruction and non-ischemic causes of myocardial injury. Then after MINOCA diagnosed, need to workup etiology. Inge van den Hoogen #SCCT2021 ImageImageImageImage
Plaque disruption and plaque erosion cause some cases of #MINOCA – diagnose with OCT or IVUS, but not CCTA. Inge van den Hoogen #SCCT2021 ImageImageImage
Read 5 tweets
Jul 16, 2021
Women are not smaller men! #Atherosclerosis genesis, progression & sequelae different in women. Plaque erosion causing ACS more common in women. Women have unique #SDOH, are undertreated with #cvPrev therapies & #GDMT, leads to worsening outcomes in women. @lesleejshaw #SCCT2021 ImageImageImage
Women’s CVD risk can be underestimated. Female specific risk enhancers help. #CAC if risk uncertain. Women have lower #CAC prevalence than men but prevalence increases after menopause. CAC when present confers greater risk of incident CVD in women than men. @lesleejshaw #SCCT2021 ImageImageImage
Prevalence of non-obstructive #CAD is higher in women but is prognostic of risk. @lesleejshaw #SCCT2021 ImageImageImage
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(